openPR Logo
Press release

Investigation announced for Investors in CareDx, Inc (NASDAQ: CDNA) over potential Wrongdoing

11-03-2021 12:18 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in CareDx, Inc (NASDAQ: CDNA) shares over potential wrongdoing at CareDx, Inc.

An investigation on behalf of investors in CareDx, Inc (NASDAQ: CDNA) shares over potential wrongdoing at CareDx, Inc.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at CareDx, Inc.

Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options. Please contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain CareDx, Inc (NASDAQ: CDNA officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Brisbane, CA based CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide.

On October 28, 2021, after the market closed, transplant diagnostics company, CareDx, Inc. released Q3 2021 financial results in which the Company disclosed it is being investigated by the U.S. Department of Justice (“DOJ”) related to its kidney testing and phlebotomy services. The Company is also being investigated by the U.S. Securities and Exchange Commission (“SEC”) for similar issues as well as certain accounting and public reporting practices, and the Company received an information request from an unnamed state agency.

Shares of CareDx, Inc (NASDAQ: CDNA) declined from $96.84 per share in June 2021, to as low as $44.57 per share on October 29, 2021.

Those who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in CareDx, Inc (NASDAQ: CDNA) over potential Wrongdoing here

News-ID: 2451433 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for CareDx

Investigation announced for Long-Term Investors in CareDx, Inc (NASDAQ: CDNA) ov …
An investigation was announced for current long-term investors in shares of CareDx, Inc (NASDAQ: CDNA) concerning potential breaches of fiduciary duties by certain directors and officers of CareDx, Inc. Investors who are current long term investors in CareDx, Inc (NASDAQ: CDNA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
NASDAQ: CDNA Investor Notice: Lawsuit alleges Misleading Statements by CareDx, I …
An investor, who purchased shares of CareDx, Inc (NASDAQ: CDNA), filed a lawsuit over alleged violations of Federal Securities Laws by CareDx, Inc. Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and for certain investors are short and strict deadlines running. Deadline: July 22, 2022. NASDAQ: CDNA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Francisco, CA based CareDx, Inc. discovers,
Investigation for Long-Term Investors in shares of CareDx, Inc (NASDAQ: CDNA) ov …
An investigation was announced concerning possible breaches of fiduciary duties by certain directors at CareDx, Inc. Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain CareDx, Inc directors breached their fiduciary duties and caused damage to the company and its shareholders. Brisbane, CA based CareDx, Inc., a
Investigation announced for Investors in CareDx, Inc (NASDAQ: CDNA) shares
CareDx, Inc is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of CareDx, Inc (NASDAQ: CDNA) concerning whether a series of statements by CareDx,
Investigation announced for Investors in shares of CareDx, Inc (NASDAQ: CDNA)
An investigation was announced concerning possible securities laws violations by CareDx, Inc s in connection with certain financial statements. Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by CareDx, Inc (regarding its business, its prospects and its operations were materially false
HLA Typing for Transplant Market 2019| Prominent Players: CareDx, Inc., Bio-Rad …
The HLA Typing for Transplant Market is set to exceed USD 0.8 billion by 2025; according to a new research study published by Global Market Insights, Inc. HLA typing for transplant market will witness lucrative growth over the forecast timeframe. Growing demand for solid organ transplants will drive HLA typing for transplant industry growth over the forecast years. These lifesaving transplants are indispensable for treating patients suffering from heart, liver,